Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.

The current system of KS classification does not reflect meaningful differences in clinicopathological presentation or disease pathogenesis. Reclassification of patients based on the presence or absence of immunosuppression is a more clinically meaningful system that may influence therapeutic approaches to KS.